Pharma execFaron Pharmaceuticals has someone new to oversee its drug development strategy. In early May, the Turku-based clinical stage biopharma company appointed Matti Karvonen as its new Medical Director. … more ➔
Dab hand at financesUS- and UK-based genomics company Inivata has appointed Timothy Shannon as Chief Financial Officer. Shannon joins Inivata fom Baxano Surgical, where he held the position of CFO and treasurer. more ➔
Keeping an eye on monitoringPhilippe Dro is taking over the helm of NeMoDevices AG, a Switzerland-based developer in the innovative monitoring of brain blood flow and oxygen levels. The previous CEO Michael Oberle will serve as … more ➔
Well-versed in regulationSwedish rare disease expert Wilson Therapeutics AB has appointed global regulatory executive Rick Lilley as Chief Regulatory Officer. more ➔
Trading upEduardo Bravo takes over as President of the Board of Directors of European Biopharmaceutical Enterprises (EBE). Bravo is CEO of Belgian stem cell-based drug developer TiGenix NV. more ➔
Neurological disorder specialistUwe Meya is taking over as Chief Medical Officer at Barcelona-based orphan drug developer Minoryx Therapeutics. Meya will advance the clinical development of Minoryx’ lead candidate MIN-102 for adrenoleukodystrophy. … more ➔
Moving on upIn July, British research service provider Envigo appointed Adrian Hardy as President and CEO. Hardy will also join Envigo’s Board of Directors. more ➔
Founder reliefUS-Dutch medical device company EndoStim, developer of neurostimulation therapy for gastroesophageal reflux disease, has named Rohan Hoare as president and CEO. He succeeds founder Bevil Hogg, who … more ➔
Kymab: Old into newAntibody veteran David Chiswell, Interim CEO and Chair of Cambridge-based antibody developer Kymab, is taking over at the company’s helm for good. Kymab’s new old CEO is stepping down from his role as … more ➔
Veterinary MandateThe EMA’s Committee for Medicinal Products for Veterinary Use (CVMP) has unanimously appointed David Murphy from Ireland as its new Chair for the next three years. Murphy, a qualified veterinarian, … more ➔
